Frederik Schmachtenberg

Frederik Schmachtenberg is a partner at the consulting firm EY and a co-author of the annual 'Swiss Biotech Report'. He has been actively involved in the biotech industry, providing insights into market trends and challenges, particularly regarding investment and regulatory issues within the sector.